Ballentine Partners’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$227K Buy
2024
Q3
Sell
2024
Q2
$542K Sell
2024
Q1
$506K Buy
2023
Q4
$209K Sell
2023
Q3
$308K Buy
2023
Q2
$257K Sell
2023
Q1
$424K Sell
2022
Q4
$526K Buy
2022
Q3
$297K Buy
2022
Q2
$273K Buy
2022
Q1
$314K Buy
2021
Q4
$455K Sell
2021
Q3
$691K Buy
2021
Q2
$378K Sell
2021
Q1
$215K Buy